Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 3
2004 2
2005 2
2006 5
2007 4
2008 3
2009 7
2010 6
2011 2
2012 4
2013 6
2014 4
2015 7
2016 4
2017 8
2018 14
2019 5
2020 12
2021 8
2022 9
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Carcinogenic mechanisms of virus-associated lymphoma.
Zhang Y, Guo W, Zhan Z, Bai O. Zhang Y, et al. Among authors: bai o. Front Immunol. 2024 Feb 28;15:1361009. doi: 10.3389/fimmu.2024.1361009. eCollection 2024. Front Immunol. 2024. PMID: 38482011 Free PMC article. Review.
Long-term outcomes with HLX01 (HanliKang®), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 study.
Qin Y, Song Y, Wang D, Bai O, Feng J, Sun X, Qiu L, Yang J, Yang Y, Wang Z, Hu J, Wang H, Su H, Jin Z, Qian W, Jin C, Zhang M, Yu D, Liu L, Chen G, Li Y, Sun T, Jin J, Bao H, Du X, Zhou H, Fu G, Shi Y. Qin Y, et al. Among authors: bai o. BMC Cancer. 2024 Jan 24;24(1):124. doi: 10.1186/s12885-024-11876-9. BMC Cancer. 2024. PMID: 38267866 Free PMC article. Clinical Trial.
Oligosecretory Waldenström macroglobulinemia exhibits excellent treatment response and outcomes.
Xiong W, Yu Y, Sun C, Du J, Cai Z, Wang Z, Cao X, Yan Y, Chen J, Huang Y, Jiang Z, Wang H, Niu T, Yang G, Xue H, Li B, Huang H, Li Z, Liu Q, Li F, Bai O, Mao M, Fu R, Wang L, Li C, Chu X, Liu L, Dong Y, Wang L, Luo J, Wei Y, Cui R, Qiu L, Li J, Yi S. Xiong W, et al. Among authors: bai o. Haematologica. 2024 Feb 1;109(2):666-670. doi: 10.3324/haematol.2023.283402. Haematologica. 2024. PMID: 37706332 Free PMC article. No abstract available.
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria.
Zhang L, Dong YJ, Peng HL, Li H, Zhang MZ, Wang HH, Liu QH, Su LP, Zhong LY, Wu WJ, Huang L, Yan XJ, Fan L, Tang WJ, Li ZL, Bi LT, Li Y, Gao GX, Gao L, Liu TB, Wei YQ, Liu Y, Yu L, Zhou H, Sun CY, Qian WB, Zou DH, Zhang HL, Ding KY, Wang XB, Bai O, Huang WR, Chen B, Yang L, Song J, Gao D, Chen T, Luo J, Wang SY, Ma LM, Fajgenbaum DC, Li J; China Castleman Disease Network (CCDN). Zhang L, et al. Among authors: bai o. Lancet Reg Health West Pac. 2023 Mar 24;34:100720. doi: 10.1016/j.lanwpc.2023.100720. eCollection 2023 May. Lancet Reg Health West Pac. 2023. PMID: 37283978 Free PMC article.
122 results